{"id":"https://openalex.org/W2188840967","doi":null,"title":"Vascular Endothelial Growth Factor Receptor Antagonist - A Target for Treating Inflammatory Disease","display_name":"Vascular Endothelial Growth Factor Receptor Antagonist - A Target for Treating Inflammatory Disease","publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W2188840967","mag":"2188840967"},"language":"en","primary_location":{"id":"pmh:oai:CiteSeerX.psu:10.1.1.173.2148","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.173.2148","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.ijpbs.net/issue-3/13-bio.pdf","raw_type":"text"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024873034","display_name":"Yadu Nandan Dey","orcid":"https://orcid.org/0000-0003-4016-4379","observed_orcids":["https://orcid.org/0000-0003-4016-4379"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yadu Nandan Dey","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4016-4379","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101819035","display_name":"Neha Yadav","orcid":"https://orcid.org/0009-0009-2617-466X","observed_orcids":["https://orcid.org/0009-0009-2617-466X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Neha Yadav","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056589879","display_name":"Mahvish Jamal","orcid":"https://orcid.org/0009-0001-1666-0244","observed_orcids":["https://orcid.org/0009-0001-1666-0244"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mahvish Jamal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5102030786","display_name":"Ajoy Kumar Ghosh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ajoy Kumar Ghosh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11469","display_name":"Lymphatic System and Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12278","display_name":"Vascular Tumors and Angiosarcomas","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.9760000109672546},{"id":"https://openalex.org/keywords/vegf-receptor-antagonist","display_name":"VEGF receptor antagonist","score":0.9760000109672546},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.9789999723434448},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.621999979019165},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.8600000143051147},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.8450000286102295},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.8080000281333923}],"concepts":[{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.7545228600502014},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.7439615726470947},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.5892404913902283},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.5531502962112427},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5417472124099731},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5247369408607483},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5141768455505371},{"id":"https://openalex.org/C150710994","wikidata":"https://www.wikidata.org/wiki/Q18034921","display_name":"Vascular endothelial growth inhibitor","level":5,"score":0.47265851497650146},{"id":"https://openalex.org/C14858245","wikidata":"https://www.wikidata.org/wiki/Q18028241","display_name":"Kinase insert domain receptor","level":5,"score":0.44244006276130676},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.4422535002231598},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.4400154650211334},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3891635835170746},{"id":"https://openalex.org/C146285616","wikidata":"https://www.wikidata.org/wiki/Q7916455","display_name":"Vascular endothelial growth factor A","level":4,"score":0.3869055211544037},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3667055666446686},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28303518891334534}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:CiteSeerX.psu:10.1.1.173.2148","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.173.2148","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.ijpbs.net/issue-3/13-bio.pdf","raw_type":"text"},{"id":"mag:2188840967","doi":null,"is_oa":false,"landing_page_url":"http://www.ijpbs.net/issue-3/13-bio.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2764788474","display_name":"International Journal of Pharma and Bio Sciences","issn_l":"0975-6299","issn":["0975-6299"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4322697007","host_organization_name":"Ubitech Solutions","host_organization_lineage":["https://openalex.org/P4322697007"],"host_organization_lineage_names":["Ubitech Solutions"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Pharma and Bio Sciences","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W32167704","https://openalex.org/W1495287184","https://openalex.org/W1559714867","https://openalex.org/W1868957569","https://openalex.org/W1985804036","https://openalex.org/W1995827857","https://openalex.org/W2017322644","https://openalex.org/W2018807343","https://openalex.org/W2045247659","https://openalex.org/W2056574134","https://openalex.org/W2062694132","https://openalex.org/W2069826874","https://openalex.org/W2090246838","https://openalex.org/W2093498435","https://openalex.org/W2108555511","https://openalex.org/W2111463055","https://openalex.org/W2146440075","https://openalex.org/W2419021405"],"related_works":["https://openalex.org/W7097570969","https://openalex.org/W2044468372","https://openalex.org/W7100033856","https://openalex.org/W2379376066","https://openalex.org/W2372908003","https://openalex.org/W2388229824","https://openalex.org/W31442639","https://openalex.org/W2053486376","https://openalex.org/W2273211921","https://openalex.org/W3162267988"],"abstract_inverted_index":{"The":[0],"present":[1],"review":[2],"of":[3,11,50,61,63,83],"literature":[4],"was":[5,35],"done":[6],"to":[7],"check":[8],"the":[9,12,21,48,55,67,76,81],"influence":[10],"main":[13],"angiogenic":[14],"factor":[15,19],"vascular":[16],"endothelial":[17],"growth":[18],"in":[20,87],"various":[22,88],"physiological":[23],"and":[24,43,58,79],"pathological":[25],"conditions":[26],"like":[27,91],"growth,":[28],"development,":[29],"tumor":[30],"formation,":[31],"arthritis":[32,95],"etc.":[33,96],"It":[34],"also":[36],"seen":[37],"that":[38],"how":[39],"VEGF":[40,52,68,77],"are":[41,71],"classified":[42],"produced":[44],"as":[45,47],"well":[46],"mechanism":[49],"action.":[51],"bind":[53],"over":[54],"specific":[56],"receptors":[57],"cause":[59],"cascade":[60],"events":[62],"angiogenesis.":[64],"So":[65],"if":[66],"receptor":[69,78],"antagonists":[70],"investigated":[72],"they":[73],"can":[74],"block":[75],"prevent":[80],"process":[82],"angiogenesis":[84],"which":[85],"occurs":[86],"chronic":[89],"inflammations":[90],"solid":[92],"tumor,":[93],"rheumatic":[94]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}